Comparison between 2D and 3D Echocardiographic Parameters used for Diagnostic and Therapeutic Purpose in Patients

S S Shakil1, D K Adhikary, S Nahar

  • 1Dr Shiblee Sadeque Shakil, Senior Consultant, Department of Cardiology, Mymensingh Medical College Hospital, Mymensingh, Bangladesh;

Insights

Three-dimensional echocardiography offers superior visualization for assessing rheumatic mitral stenosis severity, improving diagnosis and management. This advanced technique better identifies calcification and subvalvular involvement compared to traditional 2D methods.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Rheumatic heart disease (RHD) remains a significant cause of morbidity and mortality, particularly in South Asia.
  • Rheumatic mitral stenosis (MS) is the most common manifestation of RHD, requiring accurate severity assessment for effective treatment.
  • Conventional 2D echocardiography (2DE) is standard, but 3D echocardiography (3DE) offers enhanced visualization of the heart's complex structures.

Purpose of the Study:

  • To compare the diagnostic capabilities of 2D and 3D echocardiography in assessing the severity of rheumatic mitral stenosis.
  • To evaluate the utility of 3DE in identifying specific valvular and subvalvular abnormalities in rheumatic MS.
  • To determine if 3DE provides a more comprehensive assessment for therapeutic planning in chronic rheumatic MS.

Main Methods:

  • A cross-sectional observational study involving 50 subjects with rheumatic mitral stenosis.
  • Transthoracic 2D and 3D echocardiography were performed for detailed assessment of mitral valve apparatus.
  • Statistical analysis was used to compare the findings between 2DE and 3DE.

Main Results:

  • Mitral valvular area measurements were similar between 2DE and 3DE (0.98±0.24cm² vs. 0.92±0.23cm²).
  • 3DE demonstrated superior detection of calcification extent and commissural involvement (p=0.002).
  • 3DE provided better visualization of subvalvular involvement, particularly chordal adhesion (p<0.001).

Conclusions:

  • Three-dimensional echocardiography offers significant advantages over 2D echocardiography for assessing rheumatic mitral stenosis.
  • 3DE enhances the identification of key pathological features crucial for treatment decisions.
  • 3DE is a promising adjuvant tool for accurate diagnosis, management planning, and complication prediction in chronic rheumatic MS.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
70
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
197
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
90
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
126
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
138
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
88